About Recipharm
Recipharm is a company based in Jordbro (Sweden) founded in 1995 was acquired by Nichepharm in July 2024.. Recipharm has completed 8 acquisitions, including Arranta Bio, Consort Medical and Flamel Technologies. Recipharm offers products and services including ReciBioPharm Services, Sterile Fill and Finish, and Solids Manufacturing. Recipharm operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Unither, Nectar Lifesciences and CoreRx, among others.
- Headquarter Jordbro, Sweden
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Recipharm Ab
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
EQT
& 1 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Arranta Bio
& 7 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Recipharm
Recipharm offers a comprehensive portfolio of products and services, including ReciBioPharm Services, Sterile Fill and Finish, and Solids Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Development and GMP manufacture of ATMPs and viral vectors
Aseptic filling for vials, syringes, and lyophilisation processes
Development and manufacturing of tablets, capsules, and liquids
Unlock access to complete
Unlock access to complete
Software Development Team
71 people
Leadership Team
17 people
Human Resources and Administration
17 people
Sales and Marketing
13 people
Head Team
13 people
Finance and Accounting
9 people
Operations Team
6 people
Product Management Team
6 people
Unlock access to complete
Funding Insights of Recipharm
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Recipharm
Recipharm has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include EQT and Nichepharm. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
EQT is recognized as a global investment organization focused on value creation.
|
Founded Year | Domain | Location | |
|
Injectable pharmaceuticals are developed and manufactured by Nichepharm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Recipharm
Recipharm has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Arranta Bio, Consort Medical and Flamel Technologies. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of therapeutics for microbiome based diseases
|
2019 | ||||
|
CDMO offering development, cGMP manufacturing and fill/finish of biologics based on viruses and bacteria
|
2007 | ||||
|
Microbial and mammalian-derived products are developed and manufactured by GenIbet.
|
2006 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Recipharm
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Recipharm Comparisons
Competitors of Recipharm
Recipharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Unither, Nectar Lifesciences and CoreRx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| domain | founded_year | HQ Location |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| domain | founded_year | HQ Location |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| domain | founded_year | HQ Location |
CDMO with a focus on early phase drug product development
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Recipharm
Frequently Asked Questions about Recipharm
When was Recipharm founded?
Recipharm was founded in 1995.
Where is Recipharm located?
Recipharm is headquartered in Jordbro, Sweden.
Who is the current CEO of Recipharm?
Greg Behar is the current CEO of Recipharm.
What does Recipharm do?
Recipharm operates as a pharmaceutical contract development and manufacturing company (CDMO). Its dosage forms include solid dose, sterile, semi solids, beta-lactams, hormones, dry powder inhalers, granulates, and powders. It provides pharmaceutical development services, such as formulation development, clinical supplies, analytical development, stability studies, packaging development and selection, and raw material selection; and manufacturing services, also offering EU gateway release and testing, regulatory, stability studies, and customized services. It has manufacturing facilities in Sweden, France, and the United Kingdom.
Who are the top competitors of Recipharm?
Recipharm's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
What products or services does Recipharm offer?
Recipharm offers ReciBioPharm Services, Sterile Fill and Finish, and Solids Manufacturing.
How many acquisitions has Recipharm made?
Recipharm has made 8 acquisitions, including Arranta Bio, Consort Medical, and Flamel Technologies.
Who are Recipharm's investors?
Recipharm has 2 investors. Key investors include EQT, and Nichepharm.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.